Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 30Pancreatic Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Rectal Neoplasms 7Lung Neoplasms 7Gliosarcoma 7Glioblastoma 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Esophageal Neoplasms 5Carcinoma, Renal Cell 5Astrocytoma 5Adenocarcinoma of Lung 5Salivary Gland Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Ovarian Epithelial 4Bile Duct Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Oligodendroglioma 3Esthesioneuroblastoma, Olfactory 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Pancreatic Intraductal Neoplasms 2Mesothelioma, Malignant 2Medulloblastoma 2Hereditary leiomyomatosis and renal cell cancer 2

Interventions

Doxorubicin 13Zidovudine 12Vincristine 11Bleomycin 8Cyclophosphamide 7Interferon alpha-2 6Etoposide 5Dexamethasone 5sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Filgrastim 4Cytarabine 4Rituximab 3Prednisone 3Nivolumab 3interferon alfa-n1 2cabozantinib 2Thalidomide 2Isotretinoin 2Interleukin-2 2Fluorouracil 2Didanosine 2Bortezomib 2Biopsy 2Allopurinol 2prednylidene 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × HIV Infections × Erlotinib Hydrochloride × Clear all
NCT02134886 2015-10-06

Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection

National Cancer Institute (NCI)

Phase 1 Terminated
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡